CBD (cannabidiol) is a non-psychoactive compound found in Cannabis sativa and hemp plants. Its popularity has skyrocketed in recent years, with the industry forecasting a valuation of $20 billion by 2024. CBD is marketed as an option for numerous conditions and ailments, ranging from acne to chronic pain. URL https://greensociety.cc/product-category/edibles/thc-gummies/
The market is currently stifled by rules requiring CBD sales only at provincially licensed cannabis stores and by prescription or doctor’s recommendation. But a Health Canada panel’s recommendation Thursday that CBD should be sold by mainstream retailers like grocery and drug stores opens up a huge new market
CBD Unveiled: Exploring the Wellness Revolution in Canada.
The panel found that, as long as products don’t contain more than 4% THC — the psychoactive component of cannabis — and are labelled with prominent warnings about potential interactions with other medications and alcohol, CBD should be treated the same as any other dietary supplement. The panel also recommended that CBD products should carry information on the amount of THC and terpenes in each product to allow consumers to make informed decisions about dosages.
To examine this market, MJBizDaily used an automated website scraper tool to gather information on 2165 products from 70 CBD sellers in Canada. Using framing analysis, we examined how these companies represent their products to prospective consumers, including the specific medical conditions they are advertised to treat, and the product forms they are offered in. We also assessed compliance with the Cannabis Act and regulations, which came into force on October 17, 2018, by reviewing whether the sites met the required requirements to be deemed compliant.